Qinghai Spring Medicinal Resources Technology Co., Ltd. (600381.SS)
CNY 3.26
(-4.96%)
CNY 3.26
(-4.96%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 23.91 Million | -31.82 Million | -63.93 Million | -77.95 Million | -236.29 Million | -183.96 Million |
| Net Income | -266.21 Million | -287.55 Million | -248.61 Million | -319.54 Million | 5.8 Million | 68.65 Million |
| Depreciation & Amortization | 27.53 Million | 41.51 Million | 42.01 Million | 41.51 Million | 40.31 Million | 42.23 Million |
| Deferred income taxes | -504.36 Thousand | -7.83 Million | -4.03 Million | 3.17 Million | -10.23 Million | -13.03 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 108.63 Million | 47.06 Million | -5.67 Million | -16.83 Million | -253.88 Million | -190.69 Million |
| Other non-cash items | 3.11 Million | 167.14 Million | 148.34 Million | 216.91 Million | -28.53 Million | -104.16 Million |
| Investing Cash Flow | -11.87 Million | 36.15 Million | 48.65 Million | -18.13 Million | 416.19 Million | 177.35 Million |
| Investments in PPE | -13.53 Million | -822.89 Thousand | -121.79 Million | -197.63 Million | -5.28 Million | -43.51 Million |
| Acquisitions | 610.7 Thousand | 20.00 | -0.61 | 199.63 Million | 10.00 | - |
| Investment purchases | -60 Million | -909.6 Million | -989.5 Million | -537.6 Million | -1.73 Billion | -1.37 Billion |
| Sales/Maturities of investments | 61.64 Million | 946.58 Million | 1.15 Billion | 715.09 Million | 1.94 Billion | 1.7 Billion |
| Other Investing Activities | 1.65 Million | 0.50 | 170.45 Million | -197.63 Million | 211 Million | -110.92 Million |
| Financing Cash Flow | -8.53 Million | -895.35 Thousand | -484.86 Thousand | 0.61 | -1.88 Million | 29.98 Million |
| Debt repayment | -9.13 Million | -895.35 Thousand | -484.86 Thousand | - | - | -40 Million |
| Dividends payments | - | - | - | - | -1.88 Million | -11.11 Thousand |
| Common Stock Repurchased | - | - | - | - | - | -1.00 |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -8.53 Million | -895.35 Thousand | -0.64 | - | -1.88 Million | 69.99 Million |
| Accounts receivables | 21.85 Million | 50.45 Million | -13.68 Million | 71.75 Million | -182.81 Million | -122.45 Million |
| Accounts payables | 52.54 Million | -4.38 Million | 9.83 Million | -74.1 Million | -60.36 Million | -13.08 Million |
| Inventory | 34.73 Million | 8.82 Million | 2.2 Million | -17.66 Million | 257.34 Thousand | -42.12 Million |
| Other working capital | -613.33 Thousand | -7.83 Million | -4.03 Million | 3.17 Million | -10.96 Million | -148.57 Million |
| Cash at beginning of period | 168.69 Million | 164.94 Million | 180.87 Million | 276.89 Million | 99.24 Million | 76.58 Million |
| Cash at end of period | 172.25 Million | 168.69 Million | 164.94 Million | 180.87 Million | 276.89 Million | 99.24 Million |
| Capital Expenditure | -13.53 Million | -822.89 Thousand | -121.79 Million | -197.63 Million | -5.28 Million | -43.51 Million |
| Effect of forex changes on cash | 56.56 Thousand | 306.88 Thousand | -173.96 Thousand | 67.43 Thousand | -354.47 Thousand | -721.46 Thousand |
| Net cash flow / Change in cash | 3.56 Million | 3.74 Million | -15.93 Million | -96.02 Million | 177.65 Million | 22.65 Million |
| Free Cash Flow | 10.38 Million | -32.64 Million | -185.72 Million | -275.58 Million | -241.58 Million | -227.48 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -30.58 Million | -32.96 Million | -26.9 Million | -266.21 Million | -197.53 Million | -19.74 Million |
| Depreciation & Amortization | - | 8.06 Million | 8.06 Million | 27.53 Million | 27.53 Million | -13.63 Million |
| Deferred income taxes | - | - | - | -504.36 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 86.36 Million | - | 108.63 Million | 55.97 Million | -3.74 Million |
| Other non-cash items | 32.78 Million | 44.49 Million | 40.76 Million | 3.11 Million | 128.97 Million | 70.55 Million |
| Investing Cash Flow | -6.16 Million | -126.37 Thousand | -2.18 Million | -11.87 Million | -947.71 Thousand | -2.98 Million |
| Investments in PPE | -1.16 Million | -200.01 Thousand | -2.27 Million | -13.53 Million | -2.51 Million | -2.98 Million |
| Acquisitions | - | - | 31 Thousand | 610.7 Thousand | 600 Thousand | - |
| Investment purchases | -5 Million | -35 Million | - | -60 Million | - | - |
| Sales/Maturities of investments | 35.07 Million | 35.07 Million | 58.63 Thousand | 61.64 Million | 1.56 Million | - |
| Other Investing Activities | -40.07 Million | 73.64 Thousand | 89.63 Thousand | 1.65 Million | 1.56 Million | - |
| Financing Cash Flow | -21.6 Million | -16.35 Million | -1.43 Million | -8.53 Million | -3.53 Million | -711 Thousand |
| Debt repayment | - | - | - | -9.13 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 13 Million | -13 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -21.6 Million | 1.43 Million | -1.43 Million | -8.53 Million | -3.53 Million | -711 Thousand |
| Accounts receivables | - | 14.35 Million | - | 21.85 Million | 21.85 Million | 20.7 Million |
| Accounts payables | - | - | - | 52.54 Million | - | -455.54 Thousand |
| Inventory | - | 72.27 Million | - | 34.73 Million | 34.73 Million | -24.44 Million |
| Other working capital | - | -265 Thousand | - | -613.33 Thousand | -613.33 Thousand | 455.54 Thousand |
| Cash at beginning of period | 169.56 Million | 182.52 Million | 172.25 Million | 168.69 Million | 161.94 Million | 132.26 Million |
| Cash at end of period | 143.7 Million | 169.56 Million | 182.52 Million | 172.25 Million | 172.25 Million | 161.94 Million |
| Capital Expenditure | -1.16 Million | -200.01 Thousand | -2.27 Million | -13.53 Million | -2.51 Million | -2.98 Million |
| Effect of forex changes on cash | -224.4 Thousand | 51.36 Thousand | 19.86 Thousand | 56.56 Thousand | -155.83 Thousand | -59.53 Thousand |
| Net cash flow / Change in cash | -25.86 Million | -12.96 Million | 10.27 Million | 3.56 Million | 10.31 Million | 29.67 Million |
| Free Cash Flow | 1.03 Million | 3.26 Million | 11.59 Million | 10.38 Million | 12.43 Million | 30.44 Million |
688083
AXNVF
ERVFF
GODREJPROP
VGGIF
AVLP